Tokyo Smoke breaks ground by introducing four medical cannabis strains in collaboration with Aphria Inc., one of Canada's largest licensed producers of medical marijuana.
Articles
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show.
ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis
ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from using federal funds to investigate medical marijuana cases within states that have legalized medical marijuana.
Global Payout, Inc. and MoneyTrac Technology Enter the Multi-Billion Dollar CBD Market through their Agreement with H Smart, Inc.
Global Payout, Inc. ( OTC PINK : GOHE ) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC"), has completed an agreement with H Smart Inc. (a division of Marijuana Company of America, "MCOA"), a developer and distributor of innovative wellness and Cannabidiol products, for the use of MTRAC's financial technology platform.
SinglePoint, Inc. (SING) Acquires $Weed Cryptocurrency
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its purchase of the $Weed cryptocurrency from joint venture partner First Bitcoin Capital (OTC: BITCF).
SinglePoint, Inc. (SING) Provides First-Hand Look at Development of New Bitcoin Exchange
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning offered a first-hand look at its new bitcoin exchange aimed at solving the payments issues plaguing today’s cannabis industry.
ChineseInvestors.com, Inc. (CIIX) Names Keevin Gillespie as Acting President of ChineseHempOil.com Subsidiary
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed Keevin Gillespie as acting president of its wholly-owned ChineseHempOil.com, Inc. subsidiary, effective immediately.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) to Hold Web-Meeting on November 1
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Holding a Web-Meeting
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Highlights Positive Pre-Clinical Data Related to Biosynthesis Platform
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of British Columbia.
India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided compelling in vitro data
PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter
PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August.
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
Marijuana Company of America (MCOA) Stands Out among Cannabis and Hemp Industry Innovators
Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model.
India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.